Agenda

Dr. Pol Vandenbroucke is the Vice President of Global Government Affairs at Shionogi. In this role, Pol directs the company's engagement with government bodies, policymakers, and regulatory agencies around the world, including the global fight against AMR. He has dedicated his career to Clinical Development, Medical Affairs, and Marketing worldwide. Previously, he held roles overseeing Medical Strategy at Pfizer Inc. and Medical Affairs for Pfizer’s Essential Health portfolio in North America. He led Clinical Development globally for Pfizer compounds and spearheaded initiatives targeting diseases prevalent in developing regions. Dr. Vandenbroucke sits on the boards of AFAR and BIO Ventures for Global Health and serves on advisory boards for several prominent institutions. He is a Fellow of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Medicine of the United Kingdom. As a prominent speaker on health and policy issues, he also teaches at King’s College and coordinates the Medical Affairs module at IFAPP \Academy and King’s College London.

Latifat is the Principal for Health Policy and Insights for the Americas at Economist Impact. Working with a diverse team, she oversees and executes evidence-led research and health policy analysis encompassing the global health ecosystem's public and private sectors. Latifat possesses a wealth of experience spanning 15 years working in the energy sector and international development. Before joining The Economist Group, Latifat led primary healthcare systems strengthening efforts in Africa, South Asia and the Pacific Islands, working for the World Bank Group. Latifat holds an MPH in Public Health from Harvard T.H. Chan School of Public Health and a Bachelor of Science degree in Microbiology from Benson Idahosa University. She is a Doctor of Public Health candidate in Health Policy and Leadership at Loma Linda University.

Jean-Louis is Vice President, Public and Government Affairs – AMR at bioMérieux since October 2019. As a world leader in in vitro diagnostics, focusing on infectious diseases, bioMérieux has a long-standing commitment to fighting AMR. This commitment is at the heart of the Company’s mission to serve public health all around the globe.

Jean-Louis joined the company in 1984 holding roles of increasing responsibility, most recently as Vice President Global Marketing in Microbiology (2007-2011) and Vice President Northern Europe (2011-2019) which allowed him to accumulate rich experience in the field of in vitro diagnostics. He graduated from the Business School of the Conservatoire National Des Arts et Métiers in Paris and received his Master degree in Biology from the University of Paris.

Dr Raghu Sriram is a clinical microbiologist by training working with the World Health Organization (WHO) in the AMR Division. His work focuses on the strengthening of bacterial and fungal laboratory diagnostic capacity with a special focus on LMICs. Prior to joining WHO, he had 20 years’ experience of working in hospital laboratories in India. He also previously worked as the regional microbiologist (South Asia region) and subsequently as the lead clinical microbiologist with the management agent of the Fleming Fund which focused on improving AMR surveillance in Africa and Asia.